Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users

NCT06659029 · clinicaltrials.gov ↗

RECRUITING

Status

442

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Lupus Erythematosus

Interventions

DRUG: Anifrolumab

Sponsor

AstraZeneca

Collaborators

[object Object]